bronchiectasis

February 2, 2016February 3, 2016

FDA Approves IND Application for Multidrug-Resistant Bacterial Infections

Bronchiectasis, COPD, Cystic Fibrosis, Emphysema, News, Pneumonia

Matinas BioPharma Holdings recently announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application, and the company can now begin a Phase 1 clinical trial to ... Read more

January 28, 2016January 28, 2016

UC San Diego Researchers Develop Novel Detection Method for Antibiotics Resistance

Bronchiectasis, COPD, Cystic Fibrosis, News, Pneumonia

A recent article by UC San Diego researchers, published in the journal EBioMedicine, reported the development of a novel, rapid and efficient technique able to determine whether bacteria are resistant to ... Read more

January 15, 2016

Matinas BioPharma Fills IND Application for Antibacterial Drug Development

Bronchiectasis, COPD, Cystic Fibrosis, News

Matinas BioPharma of Bedminster, N.J., filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the development of its antibacterial drug MAT2501 for the ... Read more

December 1, 2015December 1, 2015

Non-CF Bronchiectasis Study Looks at Airway Clearance Techniques

Bronchiectasis, News

Non-cystic fibrosis bronchiectasis symptoms, such as chronic cough and mucus production, are often managed with the use of airway clearance techniques (ACTs), regardless of clinical status. But the efficacy of such interventions for bronchiectasis ... Read more

October 28, 2015November 6, 2015

Alitair Presents Updates on Bronchiectasis Treatments at 2015 Cavendish Forum

Bronchiectasis, News

Clinical stage pharmaceutical company Alitair Pharmaceuticals is currently presenting at the ongoing Cavendish Global Health Impact Forum in Cleveland, Ohio, which kicked off Sunday, October 25, and concludes on October 28th. The forum ... Read more

August 21, 2015November 6, 2015

Raptor Pharmaceutical Expands Its Rare Disease Portfolio For CF, Bronchiectasis By Acquiring Quinsair

Bronchiectasis, News

Raptor Pharmaceutical Corp. recently announced it has signed an agreement with Tripex Pharmaceuticals in order to acquire Quinsair, which is the first inhaled fluoroquinolone that received approval to manage chronic pulmonary infections caused Pseudomonas ... Read more

July 29, 2015November 6, 2015

Rheumatoid Arthritis-Bronchiectasis Patients Exhibit Increase in Disease Severity

Bronchiectasis, News

In a new study entitled “Increased disease activity, severity and autoantibody positivity in rheumatoid arthritis patients with co-existent bronchiectasis” researchers measured key markers of rheumatoid arthritis disease activity and severity in ... Read more

July 7, 2015November 6, 2015

Bronchiectasis Identified as a Potential HTLV-associated Disease

Bronchiectasis, News

In a recent study entitled “High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease,” a team of researchers analyzed whether the human T-lymphotropic virus type-1 (HTLV-1), the agent responsible ... Read more

June 17, 2015November 6, 2015

Bronchiectasis May Lead To a Worse Outcome in Patients With COPD

Bronchiectasis, News

Bronchiectasis is a common condition experienced by people with chronic obstructive pulmonary disease (COPD) that involves the widening of the bronchi, which are the main airways to the lungs. COPD refers to a group of ... Read more

June 10, 2015November 6, 2015

Bronchiectasis Patients Found to Have a Sedentary Lifestyle in New Study

Bronchiectasis, News

A new study published in the journal BMC Pulmonary Medicine revealed that patients with bronchiectasis tend to have an inactive, sedentary lifestyle. The study is entitled “Sedentary behavior and physical ... Read more